2020 AUG 13 Melbourne, Elderly people infected with COVID-19, Hospital does not want them, say relatives

Elderly people infected with COVID-19 are arriving at Melbourne hospitals, being refused treatment and sent back to their aged care home in a move devastating families.

One nursing home, Jewish Care in Windsor, had two residents turned away from hospitals in one day, including one who was refused admission at both The Alfred Aged Care and Cabrini Health.


Another Facility – the Glenlyn Aged Care in Glenroy – told the families of residents that Royal Melbourne Hospital “would not be accepting (residents) and they were to remain at the facility and be placed on end of life care and/or be sedated if they were wandering”.

“Please know that we have tried our utmost best to transfer the residents who we cannot isolate to the hospital but, to put it simply, the hospital does not want them,” management at Glenlyn, which is home to residents with high-care needs, told families.

Go Away & Die Pure Abuse of the Vulnerable

The Australian on Tuesday revealed aged care home residents, some in their 40’s, were being sedated instead of hospitalised or moved to another facility where they could be kept in isolation.

But Victorian health authorities are also refusing to hospitalise coronavirus-infected elderly people from aged care homes — even without clinical needs like dementia.

On August 3, Jewish Care transported one resident with COVID-19 to The Alfred but that person was refused admission and sent back to the aged care home. Another resident was sent to two hospitals and turned away at both.

“The family of the resident wanted their loved one to go to hospital but she was refused admission at both the Alfred Aged Care and Cabrini Health,” Jewish Care’s community general manager, Vanessa Cohen, wrote in correspondence seen by The Australian.

“As an Australian Citizen, I am completely dismayed to Witness First-hand the Devastating Situation in our Public Health System.”

Vanessa Cohen

Since that time, one Jewish Care resident has died, 17 staff have contracted the virus. The Windsor facility has 26 residents with coronavirus who are understood to be still in the aged care home and not in hospital.

There are now 1932 active cases relating to aged care facilities in Victoria, one-quarter of the total number. There were 16 deaths linked to known outbreaks at aged care centres — out of 21 — recorded on Wednesday.

The Department of Health and Human Services declined to comment on Tuesday and did not respond to requests for details about the latest hospital refusals on Wednesday.


But Daniel Andrews has denied aged care residents are being denied hospital treatments.

“Transfers to hospitals, the notion that people are being refused is not the advice I have,” the Victorian Premier said.

“There are some in this industry that would no longer like to have all of their residents under their roof, that would be easier perhaps.”

Mr Andrews said 476 aged care residents had been transferred to hospital. “The mere fact that the number of residents who are being transferred to hospitals continues to grow each day would indicate to me that our clinical staff are making very difficult judgments based on clinical needs and based on the circumstance of that particular resident,” he said.

But Robert Hoffman, a doctor who works in aged care homes, said hospitals had previously been quick to take patients.

“The response from the Royal Melbourne Hospital was fast and effective and 20 residents were transferred to public and private hospitals across Melbourne. This was because they were unwell or were unable to be isolated due to dementia,” he said. “Now in level four lockdown the public health response is the opposite.

Glenlyn, in its note to family members, said it had “pleaded with DHHS, the Victorian Public Health Unit, the Royal Melbourne Hospital and the Aged Care Quality and Safety Commission” for help but had been told that hospitals “did not have enough beds”.


Instead the aged care centre, which has 23 residents and six staff test positive for COVID-19, was advised to either sedate those infected if they have dementia and are at risk of wandering, or put them on end-of-life medication.


An Aged Care Clinical Advisory Committee paper, part of a federal ministerial submission provided to the aged care royal commission last year, concluded there was “clearly a problem with the overuse of anti-psychotic medications and benzodiazepines in (residential aged care)”.

Jewish Care declined to comment. 

Original Source: Date-stamped: 2020 AUG 13 | Time-stamped: 7:23AM | Author: Sharri Markson | Article Title: ‘Hospital does not want them’ | Article Link: theaustralian.com.au

2020 JUL 15 Africa to Become Testing Ground for “Trust Stamp” Vaccine Record and Payment System


Remarks: BIOMETRIC DIGITAL Identity Platform, GAVI-MASTERCARD “Wellness Pass” “Trust Stamps” via a Biometric Identity System Dual Use Tyranny Digital Identity System FULL STORY HERE: https://4cminews.com/?p=53589

GAVI-Mastercard “Wellness Pass,”

By Raul Diego. A biometric digital identity platform that “evolves just as you evolve” is set to be introduced in “low-income, remote communities” in West Africa thanks to a public-private partnership between the Bill Gates-backed GAVI vaccine alliance, Mastercard and the AI-powered “identity authentication” company, Trust Stamp.

The program, which was first launched in late 2018, will see Trust Stamp’s digital identity platform integrated into the GAVI-Mastercard “Wellness Pass,” a digital vaccination record and identity system that is also linked to Mastercard’s click-to-play system that powered by its AI and machine learning technology called NuData.

control & domination

Mastercard, in addition to professing its commitment to promoting “centralized record keeping of childhood immunization” also describes itself[1]SEE URL https://www.gavi.org/investing-gavi/funding/donor-profiles/mastercard as a leader toward a “World Beyond Cash,” and its partnership with GAVI marks a novel approach towards linking a biometric digital identity system, vaccination records, and a payment system into a single cohesive platform.

Revelation 13:16-17

16 It also forced all people, great and small, rich and poor, free and slave, to receive a mark on their right hands or on their foreheads, 17 so that they could not buy or sell unless they had the mark, which is the name of the beast or the number of its name.

The effort, since its launch nearly two years ago, has been funded via $3.8 million in GAVI donor funds in addition to a matched donation of the same amount by the Bill and Melinda Gates Foundation.

In early June, GAVI reported that Mastercard’s Wellness Pass program would be adapted in response to the coronavirus (COVID-19) pandemic.

Around a month later, Mastercard announced that Trust Stamp’s biometric identity platform would be integrated into Wellness Pass as Trust Stamp’s system is capable of providing biometric identity in areas of the world lacking internet access or cellular connectivity and also does not require knowledge of an individual’s legal name or identity to function.

The Wellness Program involving GAVI, Mastercard, and Trust Stamp will soon be launched in West Africa and will be coupled with a COVID-19 vaccination program once a vaccine becomes available.

The push to implement biometrics as part of national ID registration systems has been ongoing for many years on the continent and has become a highly politicized issue in several African countries.

Opposition to similar projects in Africa often revolves around the costs surrounding them, such as the biometric voter management system that the Electoral Commission of Ghana has been trying to implement ahead of their 2020 general election in December.

Bright Simons, honorary VP of the IMANI policy think tank, has questioned the “budgetary allocation” for the new system, claiming that the “unnecessary registration of 17 million people all over again” represents millions of dollars “being blown for reasons that nobody can explain in this country.”



Trust Stamp’s biometric identity system, largely funded by Mastercard’s massive investment in the company in February, utilizes a technology it calls Evergreen Hash that creates an AI-generated “3D mask” based on a single photo of a person’s face, palm or fingerprint.

Once this “mask” is created, much of the original data is discarded and encryption keys are created in place of a person’s name or other more traditional identifiers.

“Only a small percentage of the data that originally existed is in the hash,” Trust Stamp CEO Gareth Genner has stated. “What you have is something safer for storing because it can’t be used to directly identify you.

No one would recognize you in this huge jumble of numbers.” The result, according to Genner, is an “irreversible non-personally identifiable information” system that “protects privacy, reduces potential for misuse and allows effective inclusion when there is no other form of legal record.”

Genner also explained in a recent press release that the unique “hash” is capable of “evolving” as a new hash with updated health information is created every time a child or individual gets a vaccine.

Trust Stamp’s AI algorithms can accurately determine if different hashes belong to the same individual, meaning that “the hash evolves over time just as you evolve,” said Genner.

It is unclear how much the Wellness Pass initiative is motivated by public health concerns as opposed to free market considerations.

Indeed, the GAVI alliance, largely funded by the Bill and Melinda Gates and Rockefeller Foundations, as well as allied governments and the vaccine industry, is principally concerned with improving “the health of markets for vaccines and other immunization products,” rather than the health of individuals, according to its own website. Similarly, Mastercard’s GAVI partnership is directly linked to its “World Beyond Cash” effort, which mainly bolsters its business model that has long depended on a reduction in the use of physical cash.



Trust Stamp also shares this market-focused vision for its digital identity system as the company has stated that it is looking for new commercialization options for its Evergreen Hash Technology, specifically with prison systems.

Talks with private and public prison systems have revealed an interest in their utilization of Trust Stamp’s technology to provide identification for individuals on parole “without making them pay for pricey ankle bracelets that monitor their every move,” as digital identity system would ostensibly provide that same function but in a “touchless” and less expensive manner.

Trust Stamp’s interest in providing its technology to both COVID-19 response and to law enforcement is part of a growing trend where numerous companies providing digital solutions to  COVID-19 also offer the same solutions to prison systems and law enforcement for the purposes of surveillance and “predictive policing.”

For instance, contact tracing software originally introduced as part of the COVID-19 response has since been used by police departments across the U.S. to track protesters during the country’s recent bouts of protests and civil unrest.

Similarly, a controversial Israeli tech firm currently being used in Rhode Island offers AI-powered predictive analytic to identify likely future COVID-19 hotspots and individuals likely to contract COVID-19 in the future, while also offering governments the ability to predict future locations of and participants in riots and civil unrest.

What is perhaps most alarming about this new “Wellness Pass” initiative, is that it links these “dual use” digital solutions to cashless payment solutions that could soon become mandated as anything over than touchless, cashless, methods of payment have been treated as potential modes for contagion by GAVI-aligned groups like the World Health Organization, among others, since the pandemic was first declared earlier this year.


Hashtags: #4cminewswire, #TrustStamp, #WellnessPass, #EvergreenHashTechnology, #GAVI, #GarethGenner, #BillGates, #MelindaGates, #RockefellerFoundations, #COVID19, #nCov19, #Coronavirus, #NovelCoronavirus, #4cminews, #4CMiTV, #4CM2020JUL15

Tags: 4cminewswire, Trust Stamp, Wellness Pass, Evergreen Hash Technology, GAVI, Gareth Genner, Bill Gates, Melinda Gates, Rockefeller Foundations, COVID-19, nCov19, Coronavirus, Novel Coronavirus, 4cminews, 4CMiTV, #4CM2020JUL15,

Gab: https://gab.com/4cminewswire/posts/104539341487932913
Telegram: @Newswire4cm
Twitter: https://twitter.com/4cminews/status/1284752803500441600
Parler: https://share.par.pw/post/9bd9d68dc9ca4bdfb55687406999c21a


Original-Source: Raul Diego
Original-Source-Published:  2020 JUL 15,
Original-Source-URL: activistpost.com


4cminews tweet: 2020 JUN 10 The Retractions Of 2 COVID19 Studies; Fraudulent Nature of Scientist Has Been Revealed


This post comes from one of our syndications links which may have 3rd party Content and is subject to our Disclaimer on all content

@4cminews tweet: 2020 JUN 07 Black Lives protesters are ‘recklessly endangering lives or this COVID-19 all a con?

VIDEO: 2020 JUN 07 **Black Lives protesters are 'recklessly endangering lives Or this covid-19 all a con?** , , , , , WATCH HERE: youtu.be/TxN1q43afjI

This post comes from one of our syndications links which may have 3rd party Content and is subject to our Disclaimer on all content

@4cminews tweet: 2020 JUN 05 Hundreds of Recovered Virus Patients in China Have Relapsed, Leaked Documents Show A growing number of patients in China are relapsing

EDITORIAL: 2020 JUN 05 **Hundreds of Recovered Virus Patients in China Have Relapsed, Leaked Documents Show** , , , , , READ HERE: theepochtimes.com/hundreds-of-vi… **A growing number of patients in China are relapsing**

This post comes from one of our syndications links which may have 3rd party Content and is subject to our Disclaimer on all content

2020 MAY 29 CDC Admits COVID-19 Antibody Tests Are Wrong Half The Time & Virus Isn’t That Deadly

The mainstream media is ignoring the fact that the CDC has admitted the death rate for COVID-19 is actually lower than the flu. This is happening as the media admits that the antibody tests are wrong 50% of the time!

The scamdemic fear-mongering is ongoing and the propaganda is getting worse daily, even as their OWN DATA shows otherwise. Instead of giving the public the facts, the media continues to push for an extended lockdown, freedom trampling regulations, mass surveillance, and our permanent enslavement for their political overlords.


The CDC just came out with a report that should be earth-shattering to the narrative of the political class, yet it will go into the thick pile of vital data and information about the virus that is not getting out to the public.

For the first time, the CDC has attempted to offer a real estimate of the overall death rate for COVID-19, and under its most likely scenario, the number is 0.26 percent.

Until now, we have been ridiculed for thinking the death rate was that low, as opposed to the 3.4 percent estimate of the World Health Organization, which helped drive the panic and the lockdowns. Now the CDC is agreeing to the lower rate in plain ink.

Plus, ultimately we might find out that the IFR is even lower because numerous studies and hard counts of confined populations have shown a much higher percentage of asymptomatic cases. Simply adjusting for a 50 percent asymptomatic rate would drop their fatality rate to 0.2 percent – exactly the rate of fatality Dr. John Ionnidis of Stanford University projected.

More importantly, as I mentioned before, the overall death rate is meaningless because the numbers are so lopsided. Given that at least half of the deaths were in nursing homes, a back-of-the-envelope estimate would show that the infection fatality rate for non-nursing home residents would only be 0.1 percent or 1 in 1,000. And that includes people of all ages and all health statuses outside of nursing homes. Since nearly all of the deaths are those with comorbidities. -The Ron Paul Institute for Peace and Prosperity

This is something most people have known relatively early on, as the government continued to inflate the numbers and call every death a COVID-19 casualty so they could commit economic terrorism on the entire planet. And those antibody tests the ruling class wants us all to take before can even think about coming off house arrest? Those are only right half the time.  How did CNN spin this into more fear porn and propaganda?


Serologic test results should not be used to make decisions about returning persons to the workplace.

Health officials or health care providers who are using antibody tests need to use the most accurate test they can find and might need to test people twice, the CDC said in the new guidance. –CNN

So, you can’t be free, which is your birthright, because their tests are inaccurate. It’s actually quite shocking people are even agreeing to these tests in the first place, all to pad the numbers for this scamdemic that has been little more than a hoax since day one. This has become so blatantly ridiculous that it’s actually hard to believe there’s anyone out there still supporting the government and their puppets in the mainstream media. They want you to still be afraid.  They need you in fear.  Do not comply.

Original Source: Date-stamped: 2020 MAY 29 | Time-stamped: 21:10 | Author: Tyler Durden  Article Title:  Article Link: zerohedge.com

Original Source: Date-stamped: 2020 MAY 28 | Author: Mac Slavo | Article Title: The Cdc Admits Covid-19 Antibody Tests Are Wrong Half The Time & Virus Isn’T That Deadly | Article Link: shtfplan.com

Hashtags: #4cminewswire, #4cminews, #CDC, #COVID19, #JohnIonnidis, #4CM2020MAY28

Tags: 4cminewswire, 4cminews, CDC, COVID-19, John Ionnidis, #4CM2020MAY28

@4cminews tweet: 2020 MAY 28 Death of 30-year-old Nathan Turner from coronavirus has officials worried; SPECULATION FAKE NEWS THE CAUSE OF DEATH IS YET TO BE ESTABLISHED OK

Death of 30-year-old Nathan Turner from coronavirus has officials worried | PerthNow SPECULATION FAKE NEWS THE CAUSE OF DEATH IS YET TO BE ESTABLISHED OK! https://www.perthnow.com.au/news/coronavirus/death-of-30-year-old-nathan-turner-from-coronavirus-has-officials-worried-ng-b881560720z …

This post comes from one of our syndications links which may have 3rd party Content and is subject to our Disclaimer on all content

@4cminews tweet: 2020 MAY 24 Prof Petrovsky; Like It Was Designed to Infect Humans; COVID-19 ‘Cell Culture’

VIDEO: 2020 MAY 24 **PROF PETROVSKY; LIKE IT WAS DESIGNED TO INFECT HUMANS; COVID-19 ‘CELL CULTURE’** , , , , , , , , WATCH HERE: https://www.4cmitv.com/2020/05/27/2020-may-24-prof-petrovsky-like-it-was-designed-to-infect-humans-covid-19-cell-culture/ …

This post comes from one of our syndications links which may have 3rd party Content and is subject to our Disclaimer on all content

@4cminews tweet: 2020 MAY 26 COVID-19, 5G, Fanos Panayides Speaks to Avi Yemini

VIDEO: 2020 MAY 26 **COVID-19, 5G, FANOS PANAYIDES SPEAKS TO AVI YEMINI** , , , , , , , , , , , WATCH HERE: https://www.4cmitv.com/2020/05/26/2020-may-26-covid-19-5g-fanos-panayides-speaks-to-avi-yemini/ …

This post comes from one of our syndications links which may have 3rd party Content and is subject to our Disclaimer on all content

2020 MAY 23 The Remdesivir Study Is Finally Out: Drug Only Helped Those On Oxygen, Finds Mortality Too High For Standalone Treatment

Remember when the market soared on several days in April on the Facui-touted Remdesivir study which, according to StatNews and various other unofficial sources of rumors, was a smashing success only for the optimism to fizzle as many questions emerged, and as the Gilead drug quietly faded from the public’s consciousness and was replaced by various coronavirus vaccine candidates such as those made by the greatly hyped Moderna (whose insiders just can’t stop selling company stock).

Meanwhile, those who were waiting for the official version of Remdesivir’s effectiveness had to do so until 6pm on a Friday before a long holiday, and for good reason…

… According to a pivotal study published in the New England Journal of Medicine late on Friday, Remdesivir, which was authorized to treat Covid-19 in a group of 1063 adults and children (split into two groups, one receiving placebo instead of remdesivir) who need i) supplemental oxygen, ii) a ventilator or iii) extracorporeal membrane oxygenation (ECMO), only significantly helped those on supplemental oxygen.

Meanwhile, and explaining the 6pm release on a Friday, the study also found no marked benefit from remdesivir for those who were healthier and didn’t need oxygen or those who were sicker, requiring a ventilator or a heart-lung bypass machine.

The NEJM, almost apologetically, stated that “the lack of benefit seen in the other groups might have stemmed from a smaller number of patients in each group.”

Still, as a result of the partial benefit for patients in the supplemental oxygen group, the study from the National Institute of Allergy and Infectious Diseases was evaluated early and led to the authorization of remdesivir before the full trial was completed.

Our findings highlight the need to identify Covid-19 cases and start antiviral treatment before the pulmonary disease progresses to require mechanical ventilation.

Some more details on the study, which was a “rank test of the time to recovery with remdesivir as compared with placebo, with stratification by disease severity”:

The primary outcome measure was the time to recovery, defined as the first day, during the 28 days after enrollment, on which a patient satisfied categories 1, 2, or 3 on the eight-category ordinal scale.

The categories are as follows:

1: not hospitalized, no limitations of activities;

2: not hospitalized, limitation of activities, home oxygen requirement, or both;

3: hospitalized, not requiring supplemental oxygen and no longer requiring ongoing medical care (used if hospitalization was extended for infection-control reasons);

4: hospitalized, not requiring supplemental oxygen but requiring ongoing medical care (Covid-19–related or other medical conditions);

5: 5, hospitalized, requiring any supplemental oxygen;

6: hospitalized, requiring noninvasive ventilation or use of high-flow oxygen devices;

7: hospitalized, receiving invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); and

8: death.

The results are summarized below, highlighting the only group that showed a statistically significant improvement in outcomes as a result of taking the drug vs placebo.

A visual representation of the outcomes is below; it shows that whereas there was a modest benefit only to patients who were receiving oxygen, the results were statistically insignificant vs placebo for patients not receiving oxygen, while in a surprising twist patients on high-flow oxygen or mechanical ventilator/ECMO did modestly better in the placebo group than those taking remdesivir. Also, the overall results showed a very modest, but not statistically significant improvement in the remdesivir group vs placebo (box A).

Another disappointment: the study found that overall “mortality was numerically lower in the remdesivir group than in the placebo group, but the difference was not significant“, in other words the alleged “miracle drug” has largely the same effect as a placebo in terms of overall disease mortality.

The study authors also note that the “findings in our trial should be compared with those observed in a randomized trial from China in which 237 patients were enrolled (158 assigned to remdesivir and 79 to placebo)…. That trial failed to complete full enrollment (owing to the end of the outbreak), had lower power than the present trial (owing to the smaller sample size and a 2:1 randomization), and was unable to demonstrate any statistically significant clinical benefits of remdesivir.

Finally, the study found that while mortality was modestly lower for the remdesivir arm, it was not significantly so, at 7.1% at 14 days on drug versus 11.9% on placebo.

In conclusion, while the “preliminary findings support the use of remdesivir for patients who are hospitalized with Covid-19 and require supplemental oxygen therapy” the study goes on to warn that “given high mortality despite the use of remdesivir, it is clear that treatment with an antiviral drug alone is not likely to be sufficient.”

The study’s recommendation:

Future strategies should evaluate antiviral agents in combination with other therapeutic approaches or combinations of antiviral agents to continue to improve patient outcomes in Covid-19.

So a generally disappointing outcome, one which would lead to a drop in the market. 

Nonsense: think of all the spin, and why this is in fact great news for stocks: Remdesivir may be a dud as a “silver bullet” to curing covid, leading to statistically significant improvement in only a very limited subset of infected patients and “high mortality” for those taking it, but at least the algos will have a whole lot of other “miracle drugs” to levitate them as optimism that the next remdesivir is just around the corner.

In short: rinse, rumor, and repeat… and then save the bad news for 6pm on a Friday. Oh, and for those asking about the “official” reason why the NE Journal of Medicine waited until just the right time to make sure nobody reads the results, here it is:

Original Source: Date-stamped: 2020 MAY 23 | Author: The Remdesivir Study Is Finally Out: Drug Only Helped Those On Oxygen, Finds Mortality Too High For Standalone Treatment | Article Title:  Article Link: zerohedge.com